Washington, April 3 – The United States will impose tariffs of up to 100% on imported patented pharmaceuticals, with President Donald Trump citing national security risks and heavy reliance on foreign supply chains.In a proclamation issued on Thursday, Trump said that “pharmaceuticals and...
activepharmaceuticalingredients
china
drug pricing
healthcare
import restrictions
india
manufacturing
national security
patent drugs
pharmaceuticals
section 232
supply chains
tariffs
trade agreements
trade policy
united states
New Delhi/Dhaka, March 21 – While Bangladesh and India have engaged in extensive discussions on trade and connectivity at the bilateral level, the emergency supply security – with clearly defined, structured, and contractually binding terms – has yet to be formalised, despite its clear...
Washington, March 12 – The United States has become dangerously reliant on China for the raw materials and ingredients used in many of its most common medicines, lawmakers and expert witnesses warned at a Senate hearing, framing the issue as both a national security threat and an impending...
activepharmaceuticalingredients
arsenic
china
drug quality
generic drugs
medicines
national security
pharmaceuticals
public health
raw materials
rosemary gibson
senate committee on aging
supply chain
ted yoho
thallium
united states
New Delhi, March 10 Chemicals and Fertilizers Minister J P Nadda said on Tuesday that India's exports of active pharmaceutical ingredients (APIs) stood at around Rs 41,500 crore in the last fiscal, higher than the total imports of Rs 39,215 crore.Responding to a supplementary query during the...